Home
COVID-19
Notices
Prescription Drugs
Forms
Utilization Review and Grievance Information
HIPAA Privacy Guidelines
Clinical Review Criteria
For treatment of a child or adolescent mental disorder, reviews are based on the most recent guidelines of the
American Academy of Child and Adolescent Psychiatry's Child and Adolescent Service Intensity Instrument
For the treatment of an adult mental disorder, reviews are based on the most recent
Guidelines of the American Psychiatric Association
For treatment of a substance use disorder, reviews are based on the most recent edition of the
American Society of Addiction Medicine's Patient Placement Criteria
illumifin Corporation (DBA in California: illumifin Administration) Customer Service Number, 800-828-0153.